MetaADEDB 2.0 @ LMMD
Zonisamide
(UBQNRHZMVUUOMG-UHFFFAOYSA-N)
Structure
SMILES
NS(=O)(=O)Cc1noc2c1cccc2
Type(s)
Approved; Investigational
ATC code(s)
G01AE10; N03AX15
Molecular Formula:
C8H8N2O3S
Molecular Weight:
212.226
Log P:
2.3974
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
94.57
CAS Number(s):
68291-97-4
Synonym(s)
1.
Zonisamide
2.
3-Sulfamoylmethyl-1,2-benzisoxazole
3.
AD 810
4.
AD-810
5.
CI 912
6.
CI-912
7.
Zonegran
8.
Zonisamide Monosodium
9.
3 Sulfamoylmethyl 1,2 benzisoxazole
10.
AD810
11.
CI912
External Link(s)
MeSHD000078305
PubChem Compound11967800
5734
BindingDB50028010
35998
10888
ChEBI10127
CHEMBLCHEMBL750
DrugBankDB00909
DrugCentral2872
IUPHAR/BPS Guide to PHARMACOLOGY7047
KEGGcpd:C07504
dr:D00538
Therapeutic Target DatabaseD09ZIS
ZINC4321
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product substitution issueFAERS: 49US FAERS
2Stevens-Johnson SyndromeFAERS: 4512239465
25811541		CTD
OFFSIDES
SIDER
US FAERS
3Toxic Epidermal NecrolysisFAERS: 36SIDER
US FAERS
4HeadacheFAERS: 3517149715CTD
SIDER
US FAERS
5Therapeutic response unexpected with drug substitutionFAERS: 35US FAERS
6Drug ineffectiveFAERS: 33US FAERS
7DizzinessFAERS: 32SIDER
US FAERS
8NauseaFAERS: 2816855456CTD
SIDER
US FAERS
9VomitingFAERS: 2615238558
17157078		CTD
SIDER
US FAERS
10NephrolithiasisFAERS: 25OFFSIDES
SIDER
US FAERS
11SomnolenceFAERS: 22SIDER
US FAERS
12Pharmaceutical product complaintFAERS: 20US FAERS
13FatigueFAERS: 1917149715CTD
SIDER
US FAERS
14Drug exposure during pregnancyFAERS: 18US FAERS
15Oculomucocutaneous syndromeFAERS: 18US FAERS
16Chest PainFAERS: 16SIDER
US FAERS
17TremorFAERS: 151562387
17587636		CTD
SIDER
US FAERS
18AgranulocytosisFAERS: 12SIDER
US FAERS
19DiplopiaFAERS: 12SIDER
US FAERS
20HypersensitivityFAERS: 11SIDER
US FAERS
21PneumoniaFAERS: 11SIDER
US FAERS
22Weight decreasedFAERS: 11
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
23Alanine Aminotransferase IncreasedFAERS: 10SIDER
US FAERS
24AlopeciaFAERS: 10SIDER
US FAERS
25AtaxiaFAERS: 1015238558CTD
SIDER
US FAERS
26Feeling abnormalFAERS: 10SIDER
US FAERS
27LymphadenopathyFAERS: 10SIDER
US FAERS
28Product quality issueFAERS: 10US FAERS
29Suicide attemptFAERS: 10SIDER
US FAERS
30Aspartate Aminotransferase IncreasedFAERS: 8SIDER
US FAERS
31MalaiseFAERS: 8SIDER
US FAERS
32Metabolic acidosisFAERS: 8OFFSIDES
SIDER
US FAERS
33Neuroleptic Malignant SyndromeFAERS: 8SIDER
US FAERS
34NystagmusFAERS: 8SIDER
US FAERS
35AgitationFAERS: 7SIDER
US FAERS
36AmnesiaFAERS: 7SIDER
US FAERS
37Depressed Level of ConsciousnessFAERS: 7OFFSIDES
SIDER
US FAERS
38LeukocytosisFAERS: 7SIDER
US FAERS
39Wrong technique in product usage processFAERS: 7US FAERS
40AstheniaFAERS: 6SIDER
US FAERS
41Back PainFAERS: 6US FAERS
42Burning sensationFAERS: 6OFFSIDES
US FAERS
43DysgeusiaFAERS: 6SIDER
US FAERS
44Erythema MultiformeFAERS: 6OFFSIDES
SIDER
US FAERS
45Impaired work abilityFAERS: 6US FAERS
46LeukopeniaFAERS: 6SIDER
US FAERS
47OverdoseFAERS: 6US FAERS
48PainFAERS: 615140322
16217643
17666864		CTD
US FAERS
49SplenomegalyFAERS: 6US FAERS
50Status EpilepticusFAERS: 612833885CTD
OFFSIDES
SIDER
US FAERS
51Abdominal PainFAERS: 5SIDER
US FAERS
52AngerFAERS: 5SIDER
US FAERS
53AnxietyFAERS: 5OFFSIDES
SIDER
US FAERS
54AphasiaFAERS: 5US FAERS
55CryingFAERS: 5US FAERS
56DysphemiaFAERS: 5US FAERS
57Eosinophilic PneumoniaFAERS: 5US FAERS
58EpilepsyFAERS: 520196486CTD
OFFSIDES
US FAERS
59ErythemaFAERS: 5US FAERS
60Gamma-Glutamyltransferase IncreasedFAERS: 5OFFSIDES
US FAERS
61HypohidrosisFAERS: 5US FAERS
62Medication ErrorFAERS: 5US FAERS
63Memory impairmentFAERS: 5SIDER
US FAERS
64Mental status changesFAERS: 5US FAERS
65ParanoiaFAERS: 5US FAERS
66PhotophobiaFAERS: 5SIDER
US FAERS
67PolyuriaFAERS: 5SIDER
US FAERS
68Product measured potency issueFAERS: 5US FAERS
69Therapeutic response unexpectedFAERS: 5US FAERS
70ThrombocytopeniaFAERS: 5SIDER
US FAERS
71AbasiaFAERS: 4US FAERS
72Activities of daily living impairedFAERS: 4US FAERS
73Adverse eventFAERS: 4US FAERS
74AuraFAERS: 4OFFSIDES
US FAERS
75BruxismFAERS: 4OFFSIDES
US FAERS
76Completed SuicideFAERS: 4US FAERS
77Drug dispensing errorFAERS: 4US FAERS
78EosinophiliaFAERS: 4SIDER
US FAERS
79Feeding disorder neonatalFAERS: 4US FAERS
80HypotensionFAERS: 4SIDER
US FAERS
81MenopauseFAERS: 4US FAERS
82MyopiaFAERS: 4US FAERS
83PregnancyFAERS: 4US FAERS
84Product use complaintFAERS: 4US FAERS
85Product use issueFAERS: 4US FAERS
86RhabdomyolysisFAERS: 4OFFSIDES
SIDER
US FAERS
87StomatitisFAERS: 4SIDER
US FAERS
88TachycardiaFAERS: 4SIDER
US FAERS
89Toxicity to various agentsFAERS: 4US FAERS
90UrticariaFAERS: 4SIDER
US FAERS
91White blood cell count decreasedFAERS: 4US FAERS
92Abdominal discomfortFAERS: 3US FAERS
93Angle Closure GlaucomaFAERS: 3US FAERS
94Blood creatine phosphokinase increasedFAERS: 3SIDER
US FAERS
95CellulitisFAERS: 3US FAERS
96Cerebral InfarctionFAERS: 3US FAERS
97Cerebrovascular accidentFAERS: 3SIDER
US FAERS
98CholelithiasisFAERS: 3SIDER
US FAERS
99Complex partial seizuresFAERS: 3OFFSIDES
US FAERS
100Depressed moodFAERS: 3US FAERS
101Disease recurrenceFAERS: 3US FAERS
102Disseminated Intravascular CoagulationFAERS: 3US FAERS
103Drug administered to patient of inappropriate ageFAERS: 3US FAERS
104FlushingFAERS: 3US FAERS
105Human herpes virus 6 serology positiveFAERS: 3US FAERS
106HypomaniaFAERS: 3US FAERS
107HypopituitarismFAERS: 3US FAERS
108KetoacidosisFAERS: 3US FAERS
109Lymphocyte stimulation test positiveFAERS: 3US FAERS
110MarasmusFAERS: 3US FAERS
111MyoclonusFAERS: 3SIDER
US FAERS
112NasopharyngitisFAERS: 3US FAERS
113NeutropeniaFAERS: 3US FAERS
114Obsessive thoughtsFAERS: 3US FAERS
115PresyncopeFAERS: 3US FAERS
116Psychiatric symptomFAERS: 3OFFSIDES
US FAERS
117Seizure like phenomenaFAERS: 3US FAERS
118Skin lesionFAERS: 3US FAERS
119Vanishing bile duct syndromeFAERS: 3US FAERS
120Altered state of consciousnessFAERS: 2OFFSIDES
US FAERS
121AngioedemaFAERS: 2US FAERS
122AnorexiaFAERS: 2SIDER
US FAERS
123Anticonvulsant drug level decreasedFAERS: 2US FAERS
124ArthralgiaFAERS: 2SIDER
US FAERS
125Atrial FibrillationFAERS: 2SIDER
US FAERS
126Blood alkaline phosphatase increasedFAERS: 2US FAERS
127Blood creatinine increasedFAERS: 2OFFSIDES
SIDER
US FAERS
128Blood glucose increasedFAERS: 2US FAERS
129Blood potassium decreasedFAERS: 2US FAERS
130Blood urea increasedFAERS: 2SIDER
US FAERS
131Blood urine presentFAERS: 2US FAERS
132Bone painFAERS: 2US FAERS
133BradycardiaFAERS: 2SIDER
US FAERS
134CachexiaFAERS: 2US FAERS
135Capsule issueFAERS: 2US FAERS
136CataractFAERS: 2US FAERS
137ConstipationFAERS: 2SIDER
US FAERS
138Conversion disorderFAERS: 2US FAERS
139DeliriumFAERS: 2US FAERS
140Diabetes MellitusFAERS: 2US FAERS
141Disease ProgressionFAERS: 2US FAERS
142DisorientationFAERS: 2US FAERS
143Drug administration errorFAERS: 2US FAERS
144Drug level changedFAERS: 2US FAERS
145Drug level decreasedFAERS: 2US FAERS
146Drug toxicityFAERS: 2OFFSIDES
US FAERS
147DysarthriaFAERS: 2SIDER
US FAERS
148DyspepsiaFAERS: 2SIDER
US FAERS
149DysuriaFAERS: 2SIDER
US FAERS
150EczemaFAERS: 2SIDER
US FAERS
151Electroencephalogram abnormalFAERS: 2US FAERS
152Erythema InfectiosumFAERS: 2US FAERS
153Euphoric moodFAERS: 2SIDER
US FAERS
154Eye irritationFAERS: 2US FAERS
155Eye painFAERS: 2US FAERS
156FractureFAERS: 2US FAERS
157Freezing phenomenonFAERS: 2US FAERS
158Gastrointestinal perforationFAERS: 2US FAERS
159General physical health deteriorationFAERS: 2US FAERS
160Granulocyte count decreasedFAERS: 2OFFSIDES
US FAERS
161Heat StrokeFAERS: 2SIDER
US FAERS
162Heat illnessFAERS: 2US FAERS
163Hepatitis CFAERS: 2US FAERS
164HepatitisFAERS: 2US FAERS
165HepatotoxicityFAERS: 2US FAERS
166Histiocytosis haematophagicFAERS: 2US FAERS
167HydronephrosisFAERS: 2SIDER
US FAERS
168HypersomniaFAERS: 2US FAERS
169HypothyroidismFAERS: 2US FAERS
170Ideas of referenceFAERS: 2US FAERS
171IleusFAERS: 2US FAERS
172Increased tendency to bruiseFAERS: 2US FAERS
173InfectionFAERS: 2SIDER
US FAERS
174Lacrimation decreasedFAERS: 2US FAERS
175Maternal exposure during pregnancyFAERS: 2US FAERS
176Mucosal erosionFAERS: 2OFFSIDES
US FAERS
177Musculoskeletal discomfortFAERS: 2SIDER
US FAERS
178MydriasisFAERS: 2US FAERS
179No adverse eventFAERS: 2US FAERS
180Obsessive-Compulsive DisorderFAERS: 2US FAERS
181Oropharyngeal painFAERS: 2US FAERS
182PancreatitisFAERS: 2SIDER
US FAERS
183Pharyngolaryngeal PainFAERS: 2US FAERS
184Product use in unapproved indicationFAERS: 2US FAERS
185Protein-losing gastroenteropathyFAERS: 2US FAERS
186PruritusFAERS: 2SIDER
US FAERS
187Rash erythematousFAERS: 2US FAERS
188RestlessnessFAERS: 2US FAERS
189Roseolovirus test positiveFAERS: 2US FAERS
190StressFAERS: 2OFFSIDES
US FAERS
191TachyphreniaFAERS: 2US FAERS
192Therapy non-responderFAERS: 2US FAERS
193Urinary IncontinenceFAERS: 2SIDER
US FAERS
194Urinary RetentionFAERS: 2SIDER
US FAERS
195Urinary tract infectionFAERS: 2SIDER
US FAERS
196VertigoFAERS: 2SIDER
US FAERS
197Viral myocarditisFAERS: 2US FAERS
198Visual ImpairmentFAERS: 2US FAERS
199jaundiceFAERS: 2US FAERS
200treatment failureFAERS: 2US FAERS
201Accidental exposure to productFAERS: 1US FAERS
202AcidosisFAERS: 1US FAERS
203Acute kidney injuryFAERS: 1US FAERS
204AnhidrosisFAERS: 1SIDER
US FAERS
205Anticonvulsant drug level above therapeuticFAERS: 1US FAERS
206AnuriaFAERS: 1US FAERS
207ApathyFAERS: 1OFFSIDES
US FAERS
208Apparent deathFAERS: 1OFFSIDES
US FAERS
209AppendicitisFAERS: 1US FAERS
210AsthmaFAERS: 1US FAERS
211AtelectasisFAERS: 1US FAERS
212B-lymphocyte count decreasedFAERS: 1US FAERS
213Bipolar DisorderFAERS: 115383137
16855456		CTD
US FAERS
214BlindnessFAERS: 1US FAERS
215Blood immunoglobulin G decreasedFAERS: 1US FAERS
216Blood immunoglobulin M decreasedFAERS: 1US FAERS
217Blood lactate dehydrogenase increasedFAERS: 1SIDER
US FAERS
218Blood pressure fluctuationFAERS: 1OFFSIDES
US FAERS
219Brain stem syndromeFAERS: 1US FAERS
220Breast engorgementFAERS: 1US FAERS
221BronchitisFAERS: 1US FAERS
222CandidiasisFAERS: 1US FAERS
223Cardiac ArrestFAERS: 1US FAERS
224Cardiac HypertrophyFAERS: 1US FAERS
225Carpal Tunnel SyndromeFAERS: 1US FAERS
226Cerebral disorderFAERS: 1US FAERS
227Cerebral ventricle dilatationFAERS: 1US FAERS
228ChillsFAERS: 1US FAERS
229ChoreaFAERS: 1US FAERS
230ChromaturiaFAERS: 1US FAERS
231Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
232Conjunctival erosionFAERS: 1US FAERS
233CytopeniaFAERS: 1US FAERS
234Deafness NeurosensoryFAERS: 1US FAERS
235DehydrationFAERS: 1SIDER
US FAERS
236Delusional disorder, persecutory typeFAERS: 1US FAERS
237Diabetes mellitus inadequate controlFAERS: 1OFFSIDES
US FAERS
238Double Outlet Right VentricleFAERS: 1US FAERS
239Drug DependenceFAERS: 1US FAERS
240Drug dose omissionFAERS: 1US FAERS
241Drug level below therapeuticFAERS: 1US FAERS
242Drug level fluctuatingFAERS: 1US FAERS
243Drug level increasedFAERS: 1US FAERS
244Drug prescribing errorFAERS: 1US FAERS
245Drug screen false positiveFAERS: 1US FAERS
246Drug withdrawal convulsionsFAERS: 1US FAERS
247Drug withdrawal syndromeFAERS: 1US FAERS
248DystoniaFAERS: 1US FAERS
249Ear discomfortFAERS: 1US FAERS
250Economic problemFAERS: 1US FAERS
251Educational problemFAERS: 1US FAERS
252Emotional disorderFAERS: 1US FAERS
253Eosinophil percentage increasedFAERS: 1US FAERS
254Epileptic auraFAERS: 1US FAERS
255Epileptic psychosisFAERS: 1US FAERS
256EpistaxisFAERS: 1US FAERS
257ExcoriationFAERS: 1OFFSIDES
US FAERS
258Febrile infectionFAERS: 1US FAERS
259Feeling ColdFAERS: 1US FAERS
260Flank PainFAERS: 1SIDER
US FAERS
261Flat affectFAERS: 1US FAERS
262Food aversionFAERS: 1US FAERS
263Foreign body traumaFAERS: 1US FAERS
264FrustrationFAERS: 1US FAERS
265Gastric mucosal lesionFAERS: 1US FAERS
266GlossitisFAERS: 1SIDER
US FAERS
267Head discomfortFAERS: 1US FAERS
268HepatosplenomegalyFAERS: 1US FAERS
269HerniaFAERS: 1US FAERS
270Herpes simplex serology positiveFAERS: 1US FAERS
271HyperacusisFAERS: 1US FAERS
272HyperphagiaFAERS: 1US FAERS
273HypogeusiaFAERS: 1US FAERS
274HypophagiaFAERS: 1US FAERS
275Impaired driving abilityFAERS: 1US FAERS
276Impaired gastric emptyingFAERS: 1US FAERS
277Incorrect dose administeredFAERS: 1OFFSIDES
US FAERS
278Increased bronchial secretionFAERS: 1US FAERS
279Infectious MononucleosisFAERS: 1US FAERS
280Infectious pleural effusionFAERS: 1US FAERS
281Initial insomniaFAERS: 1US FAERS
282Intentional product use issueFAERS: 1US FAERS
283Intercepted drug dispensing errorFAERS: 1US FAERS
284Intercepted drug prescribing errorFAERS: 1US FAERS
285Intestinal ObstructionFAERS: 1US FAERS
286Joint Range of Motion DecreasedFAERS: 1US FAERS
287Joint stiffnessFAERS: 1US FAERS
288LethargyFAERS: 1US FAERS
289Lip erosionFAERS: 1OFFSIDES
US FAERS
290Lip swellingFAERS: 1US FAERS
291Lymphocyte percentage increasedFAERS: 1US FAERS
292Lymphocytic infiltrationFAERS: 1US FAERS
293MalnutritionFAERS: 1SIDER
US FAERS
294Measles antibody positiveFAERS: 1US FAERS
295Medication residue presentFAERS: 1US FAERS
296Mental RetardationFAERS: 1US FAERS
297Mental disorder due to a general medical conditionFAERS: 1US FAERS
298Mental impairmentFAERS: 1US FAERS
299MetamorphopsiaFAERS: 1US FAERS
300Middle insomniaFAERS: 1US FAERS
301MonoparesisFAERS: 1US FAERS
302Mood swingsFAERS: 1SIDER
US FAERS
303Multiple SclerosisFAERS: 1US FAERS
304Muscle RigidityFAERS: 11562387CTD
US FAERS
305Muscle SpasticityFAERS: 1US FAERS
306Musculoskeletal PainFAERS: 1US FAERS
307Musculoskeletal stiffnessFAERS: 1SIDER
US FAERS
308MyalgiaFAERS: 1SIDER
US FAERS
309Myocardial InfarctionFAERS: 1US FAERS
310MyocarditisFAERS: 1US FAERS
311Myoclonic EpilepsyFAERS: 1US FAERS
312Neck PainFAERS: 1US FAERS
313Negative thoughtsFAERS: 1US FAERS
314Neonatal disorderFAERS: 1US FAERS
315Neonatal hypotensionFAERS: 1US FAERS
316Neonatal respiratory failureFAERS: 1US FAERS
317Nerve injuryFAERS: 1US FAERS
318Neutrophil count decreasedFAERS: 1OFFSIDES
US FAERS
319Oral candidiasisFAERS: 1US FAERS
320Overlap syndromeFAERS: 1US FAERS
321PCO2 increasedFAERS: 1US FAERS
322PallorFAERS: 1US FAERS
323PalpitationsFAERS: 1SIDER
US FAERS
324ParotitisFAERS: 1US FAERS
325Personality ChangeFAERS: 1OFFSIDES
US FAERS
326Pharmaceutical product counterfeitFAERS: 1US FAERS
327PharyngitisFAERS: 1SIDER
US FAERS
328Physical product label issueFAERS: 1US FAERS
329Procedural complicationFAERS: 1US FAERS
330Product comminglingFAERS: 1US FAERS
331Product dispensing errorFAERS: 1US FAERS
332Product dose omissionFAERS: 1US FAERS
333Product formulation issueFAERS: 1US FAERS
334Product packaging quantity issueFAERS: 1US FAERS
335Product physical issueFAERS: 1US FAERS
336Psychotic disorder due to a general medical conditionFAERS: 1US FAERS
337Pulmonary HypertensionFAERS: 1US FAERS
338PurpuraFAERS: 1US FAERS
339PyelonephritisFAERS: 1OFFSIDES
US FAERS
340Quality of life decreasedFAERS: 1US FAERS
341Reaction to drug excipientsFAERS: 1US FAERS
342Rectal ProlapseFAERS: 1US FAERS
343Renal ColicFAERS: 1US FAERS
344Renal tubular acidosisFAERS: 1SIDER
US FAERS
345Retinal DetachmentFAERS: 1US FAERS
346Selective MutismFAERS: 1US FAERS
347SinusitisFAERS: 1US FAERS
348Skin ErosionFAERS: 1US FAERS
349Skin lacerationFAERS: 1US FAERS
350Skin reactionFAERS: 1US FAERS
351SteatohepatitisFAERS: 1US FAERS
352StridorFAERS: 1US FAERS
353Sudden deathFAERS: 1US FAERS
354TalipesFAERS: 1US FAERS
355Tardive DyskinesiaFAERS: 1US FAERS
356Therapeutic product cross-reactivityFAERS: 1US FAERS
357Therapy cessationFAERS: 1US FAERS
358Therapy changeFAERS: 1US FAERS
359ThyroiditisFAERS: 1US FAERS
360TinnitusFAERS: 1SIDER
US FAERS
361Transaminases increasedFAERS: 1US FAERS
362UnderweightFAERS: 1US FAERS
363Unevaluable eventFAERS: 1US FAERS
364Unresponsive to stimuliFAERS: 1OFFSIDES
US FAERS
365Ureteral stent insertionFAERS: 1US FAERS
366Urinary sediment presentFAERS: 1US FAERS
367Vaginal DischargeFAERS: 1US FAERS
368Visual disturbanceFAERS: 1US FAERS
369Vocal Cord ParalysisFAERS: 1US FAERS
370Wrong product administeredFAERS: 1US FAERS
371furuncleFAERS: 1US FAERS
372Abdominal tendernessOFFSIDES
373AbuseOFFSIDES
374Acute psychosisSIDER
375Acute sinusitisOFFSIDES
376AdenitisOFFSIDES
377AgraphiaOFFSIDES
378AlbuminuriaSIDER
379Alcohol abuseOFFSIDES
380AmblyopiaSIDER
381Ammonia increasedOFFSIDES
382AmphetaminesOFFSIDES
383Ankle FractureOFFSIDES
384Anti-erythropoietin antibody positiveOFFSIDES
385Anticholinergic SyndromeOFFSIDES
386Anticonvulsant drug level increasedOFFSIDES
387Antidepressant drug levelOFFSIDES
388Antiphospholipid SyndromeOFFSIDES
389Application site erythemaOFFSIDES
390Application site rashOFFSIDES
391ArteriosclerosisOFFSIDES
392ArthritisSIDER
393Arthropod biteOFFSIDES
394AutomatismOFFSIDES
395Bladder painSIDER
396Blood and lymphatic system disordersSIDER
397Blood thyroid stimulating hormone increasedOFFSIDES
398Blood uric acidOFFSIDES
399Bone density decreasedOFFSIDES
400BradyphreniaSIDER
401Cerebral PalsyOFFSIDES
402CholangitisSIDER
403CholecystitisOFFSIDES
SIDER
404Chronic Fatigue SyndromeOFFSIDES
405Circumoral paresthesiaSIDER
406ColitisSIDER
407Compulsive shoppingOFFSIDES
408ConfabulationOFFSIDES
409Congenital hiatus herniaOFFSIDES
410ConjunctivitisSIDER
411Cramps of lower extremitiesSIDER
412Creatine Phosphokinase IncreasedSIDER
413DeafnessOFFSIDES
SIDER
414Depressive disorder16855456CTD
415DermatitisSIDER
416DiabetesOFFSIDES
417Diabetic NephropathyOFFSIDES
418DiscomfortSIDER
419Disturbance in sexual arousalSIDER
420DrowsinessOFFSIDES
421Drug ToleranceOFFSIDES
422Drug screen positiveOFFSIDES
423Dry skinOFFSIDES
SIDER
424DuodenitisSIDER
425Dysthymic DisorderOFFSIDES
426EcchymosisSIDER
427Emphysematous bullaOFFSIDES
428EnuresisSIDER
429Eosinophil percentage decreasedOFFSIDES
430Epilepsies, Partial

View details

3691417
3924586
11558140
15140322
 		CTD
431Epilepsy, Complex Partial8293614CTD
432Erectile dysfunctionSIDER
433ErythromelalgiaOFFSIDES
434Essential Tremor17149715
18297619		CTD
435Exanthema15140322CTD
436Facial paralysisSIDER
437Fanconi SyndromeOFFSIDES
438FlatulenceSIDER
439GastritisSIDER
440GastroenteritisSIDER
441Gastrointestinal Diseases3924586CTD
442Gastrointestinal PainSIDER
443Genital erosionOFFSIDES
444Gingival HyperplasiaSIDER
445GingivitisSIDER
446GlaucomaSIDER
447Hallucinations12523465CTD
448HemiplegiaOFFSIDES
449HirsutismSIDER
450HydrocephalusOFFSIDES
451Hyperalgesia18544896CTD
452HyperkinesiaSIDER
453HyperreflexiaSIDER
454HyperventilationOFFSIDES
455HypokinesiaSIDER
456HypometabolismOFFSIDES
457IncoherentOFFSIDES
458Incorrect route of drug administrationOFFSIDES
459Increased upper airway secretionOFFSIDES
460InfluenzaSIDER
461IritisSIDER
462Joint sprainOFFSIDES
463Lack of spontaneous speechOFFSIDES
464Lactic dehydrogenase activity increasedSIDER
465LeukoaraiosisOFFSIDES
466LeukoencephalopathyOFFSIDES
467LordosisOFFSIDES
468Lung Diseases, Interstitial17228818CTD
469Lupus ErythematosusSIDER
470MastitisSIDER
471MenorrhagiaSIDER
472Multiple Myeloma11868602CTD
473Muscle relaxant therapySIDER
474Muscle strainOFFSIDES
475Musculoskeletal chest painOFFSIDES
476Myasthenic SyndromeSIDER
477Myoclonic Epilepsies, Progressive9477142CTD
478Neck stiffnessSIDER
479Nervous tensionOFFSIDES
480NervousnessSIDER
481Neuralgia18544896CTD
482NeuritisSIDER
483NeuropathySIDER
484NocturiaSIDER
485Nuchal RigiditySIDER
486Oculogyric crisisSIDER
487Pacemaker generated rhythmOFFSIDES
488PancytopeniaSIDER
489Paresthesia17149715CTD
490Parkinson Disease

View details

11755227
13677302
17200492
19594199
20196486
 		CTD
491Pathogen resistanceOFFSIDES
492Peptic UlcerSIDER
493Perivascular dermatitisOFFSIDES
494PetechiaeSIDER
495PleurisyOFFSIDES
496Pneumocystis jiroveci pneumoniaOFFSIDES
497Positron emission tomogram abnormalOFFSIDES
498Post procedural infectionOFFSIDES
499Pre-existing condition improvedOFFSIDES
500Prostate cancer recurrentOFFSIDES
501Pulmonary EmbolismSIDER
502Renal tubular disorderOFFSIDES
503RetrocollisOFFSIDES
504RhinitisSIDER
505SclerodermaOFFSIDES
506ScotomaSIDER
507Seizures

View details

1563341
9046859
9806000
9844417
10029267
11044598
11442880
11518630
11755227
11879338
12523465
12941455
15238558
15946322
16180713
16876388
16938433
18455367
19716464
 		CTD
508ShockSIDER
509Skin hypertrophyOFFSIDES
510Speech and language abnormalitiesSIDER
511SweatingSIDER
512SyncopeSIDER
513TensionSIDER
514ThirstCanada Vigilance: 1Canada Vigilance
SIDER
515ThrombophlebitisSIDER
516Tooth LossOFFSIDES
517Transmission of an infectious agent via a medicinal productOFFSIDES
518Ulcerative stomatitisSIDER
519Unverricht-Lundborg Syndrome11814737CTD
520Urine output increasedSIDER
521Urine potassium increasedOFFSIDES
522VIIth nerve paralysisSIDER
523Vascular insufficiencySIDER
524Vesiculobullous rashSIDER
525Walking aid userOFFSIDES
526nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.